We would like to thank our members for taking the time to complete our international survey of gynecologic cancer care providers to help us better understand the global impact of the COVID-19 pandemic on cancer care in the initial months of the pandemic. An executive summary of the results is now available.
We received responses from a total of 270 participants from 62 countries, with representation largely from North America, South America, and Asia. 83% were gynecologic oncologists and the rest included medical oncologists, radiation oncologists, pathologists, and nurses. The primary practice of 97% of participants is in clinical work and 91% work in an urban setting. 70% work in academic medical centers while 26% work in community hospitals.
From the survey responses, we learned that there is a definite and urgent need for the IGCS to comprehensively evaluate and understand the impact of the COVID-19 pandemic on gynecologic cancer practice and women’s cancer care. This understanding goes to the raison d’être of the Society in supporting its membership through education, advocacy, and political activism for women living with cancer all over the world. If you are interested in informational resources IGCS has compiled related to cancer care and COVID-19, please visit our COVID-19 page for resources, articles and recordings of educational tumor boards.
I would also like to thank Dr. Joseph Ng, IGCS Council Member and Chair of the Mentorship and Training Committee for his work in developing the survey questions and Dr. Li Min Lim for analyzing and compiling the executive summary.
The IGCS will be diving deeper and into some of the comments and responses you have provided. We intend to share what we find on these deep dives across our entire suite of information-distribution platforms including social media and in our society journal, the International Journal of Gynecological Cancer.